Nwam LLC Natera, Inc. Transaction History

Nwam LLC

$339 Million
Q2 2024

A detailed history of Nwam LLC transactions in Natera, Inc. stock. As of the latest transaction made, Nwam LLC holds 9,660 shares of NTRA stock, worth $1.25 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

9,660

Previous 9,660 -0.0%

Holding current value

$1.25 Million

Previous $883,000 18.46%

% of portfolio

0.31%

Previous 0.07%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$59.21 - $92.9 $129,669 - $203,451	-2,190 Reduced 18.48%	9,660 $883,000
Q1 2022 May 12, 2022	BUY	$30.32 - $91.33 $121,280 - $365,320	4,000 Added 50.96%	11,850 $482,000
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $8,626 - $11,900	-100 Reduced 1.26%	7,850 $733,000
Q1 2021 Apr 23, 2021	SELL	$91.47 - $124.36 $297,277 - $404,170	-3,250 Reduced 29.02%	7,950 $807,000
Q4 2020 Jan 22, 2021	SELL	$66.66 - $111.74 $259,974 - $435,786	-3,900 Reduced 25.83%	11,200 $1.12 Million
Q2 2020 Jul 21, 2020	BUY	$26.36 - $49.86 $398,036 - $752,886	15,100 New	15,100 $753,000

Others Institutions Holding NTRA

# of Institutions

504

Shares Held

120M

Call Options Held

412K

Put Options Held

270K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.6B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account